trending Market Intelligence /marketintelligence/en/news-insights/trending/Ku0zTJUFgPj2JS73y2Gu9w2 content esgSubNav
In This List

Seattle Genetics director resigns

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Seattle Genetics director resigns

John McLaughlin resigned as a director of Seattle Genetics Inc. to focus on his responsibilities as president and CEO of PDL BioPharma Inc., effective Dec. 16.

Following McLaughlin's resignation, Daniel Welch was appointed to the board's audit committee.

Welch is an independent director of Seattle Genetics.